# Main Agent Report

RUN_ID: `20260422T134401Z`

## Scope

- Task type: documentation-only repository work.
- Main worktree: original repository worktree.
- Branch: `master`.
- HEAD: `7071136c8d9fcd55e9edd9373def0aa005dc737c`.
- No live ORCA execution.
- No ORCA connection test.
- No credentials requested or used.
- No browser e2e or fullflow execution.
- No production app code changes.
- No CWP-01/02/03/04/05/06 functional changes.
- No commit.

## Evidence Review

The main agent reviewed the mandatory repo-local docs when present, including codex context, WO-3, WO-4, WO-5, WO-6, WO-7, WO-8, release validation, managerdocs, and the DADS reference.

WO-8 was found in the main worktree and incorporated. Its final verdict is `PHASE4_BLOCKED_HARNESS_OR_EVIDENCE_POLICY`; live ORCA action remained `not_run`.

One expected input path was missing: `docs/implementation/unified-clinical-wave1-batch1-wo3-20260421/CWP01_KARTE_ORDER_PERSISTENCE_REPORT.md`. The available CWP-01 equivalent evidence source is `docs/implementation/unified-clinical-wave1-batch1-wo3-20260421/CWP01_INTEGRATION_GATE_REPORT.md`.

## Consolidated Claim Boundary

- Clinical Wave 1 local/server/component/static evidence exists for CWP-01/02/03/04/05/06.
- Browser e2e is not verified by the reviewed Clinical Wave 1 evidence.
- Fullflow is not run.
- Live ORCA evidence is limited to prior Phase 3 `acceptmodv2` for `00001 / 00001`.
- WO-8 did not add live ORCA evidence.
- `medicalmodv2`, `diseasev3`, and `subjectivesv2` live success are not claimed.
- Production ORCA readiness is out of scope for this Trial-only roadmap and not claimed.

## Subagents

Subagents were used for offline advisory review in individual worktrees. Initial read-only advisory agents did not complete in useful time and were shut down; worker agents were then launched with write ownership limited to advisory markdown reports inside their own worktrees. Main-agent conclusions do not depend on any advisory finding that would strengthen claims beyond repo-local evidence.

## Misuse Cases Considered

| Misuse case | Control in this roadmap |
|---|---|
| Local/static tests are presented as live ORCA success. | Matrices cap Clinical Wave 1 at local/server/component/static. |
| Prior `00001` acceptmodv2 success is generalized to all ORCA endpoints or patients. | ORCA matrix limits it to Trial `acceptmodv2` `00001` only. |
| WO-8 no-live result is treated as business success. | WO-8 is recorded as blocked before live traffic; business success not assessed. |
| Production readiness is inferred from Trial evidence. | Production ORCA is `NOT_APPLICABLE_TRIAL_ONLY`; Trial evidence must not be used for production ORCA readiness claims. |
| Raw evidence is requested to fill gaps. | Gaps are marked pending; raw ORCA/network/patient/credential artifacts remain prohibited. |

## Package Note

Final ZIP metadata is stored in external sidecars to avoid self-referential package hash drift. The final report outside the ZIP is updated with final ZIP path, SHA-256, size, and file count after packaging.
